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The production of virulence factors including cholera toxin and the
toxin-coregulated pilus in the human pathogen Vibrio cholerae is
strongly influenced by environmental conditions. The well-charac-
terized ToxR signal transduction cascade is responsible for sensing
and integrating the environmental information and controlling the
virulence regulon. We show here that, in addition to the known
components of the ToxR signaling circuit, quorum-sensing regula-
tors are involved in regulation of V. cholerae virulence. We focused
on the regulators LuxO and HapR because homologues of these
two proteins control quorum sensing in the closely related lumi-
nous marine bacterium Vibrio harveyi. Using an infant mouse
model, we found that a luxO mutant is severely defective in
colonization of the small intestine. Gene arrays were used to
profile transcription in the V. cholerae wild type and the luxO
mutant. These studies revealed that the ToxR regulon is repressed
in the luxO mutant, and that this effect is mediated by another
negative regulator, HapR. We show that LuxO represses hapR
expression early in log-phase growth, and constitutive expression
of hapR blocks ToxR-regulon expression. Additionally, LuxO and
HapR regulate a variety of other cellular processes including
motility, protease production, and biofilm formation. Together
these data suggest a role for quorum sensing in modulating
expression of blocks of virulence genes in a reciprocal fashion
in vivo.
The Gram-negative bacterium Vibrio cholerae usually inhabitsnatural aquatic environments, but it is best known as the
causative agent of cholera, a severe diarrheal disease (1). Two
factors are critical to V. cholerae virulence—cholera enterotoxin
(CT) and an intestinal colonization factor known as the toxin-
coregulated pilus (TCP). Poorly characterized environmental
cues influence the expression of CT and TCP in vivo (2). Two
sensory proteins, ToxR and TcpP, likely play a role in detection
of the environmental signals, and then initiate a signal trans-
duction cascade that promotes the expression of ToxT, which in
turn, directly activates the transcription of genes involved in TCP
and CT expression (3).
Recent work has established that many species of bacteria
monitor their cell-population densities through the exchange of
chemical signaling molecules (called autoinducers) that accu-
mulate extracellularly and trigger alterations in behavior at high
population densities. This phenomenon is referred to as quorum
sensing (4, 5). Quorum sensing controls processes that include
bioluminescence, virulence, biofilm formation, and sporulation
in various bacterial species. In general, quorum sensing regulates
processes that are effective only when a population of bacteria
acts in a coordinated manner, but not when the bacteria act as
individuals. Gram-negative bacteria typically use acyl-
homoserine lactones as autoinducers (5, 6), whereas Gram-
positive bacteria usually use modified oligopeptides as the
communication signals (5–7). A link between quorum sensing
and virulence has been established for only a few bacterial
pathogens, most notably Pseudomonas aeruginosa (8) and Staph-
ylococcus aureus (9).
The marine bacterium Vibrio harveyi uses a complicated
quorum-sensing system to regulate bioluminescence and other
phenotypes (10). V. harveyi produces two autoinducers, a ho-
moserine lactone autoinducer (AI-1) and a second quorum-
sensing autoinducer (AI-2) that was recently found to be a borate
diester (11, 12). Detection of and response to AI-1 and AI-2
occurs through two parallel two-component signal transduction
circuits (10, 13, 14), and a shared response regulator called LuxO
integrates the information from these two circuits (15). LuxO
negatively regulates luminescence expression, presumably by
activating a putative downstream repressor of the luciferase
operon (luxCDABE) (16). Additionally, a positive regulator
called LuxR is required for transcription of the genes encoding
luciferase (17, 18). LuxR is a close homologue of the V. cholerae
protease regulatory protein HapR (19).
Analysis of the completed V. cholerae genome (20) reveals that
although V. cholerae lacks the genes required for light production
(luxCDABE), it possesses the genes required for production and
response to the quorum-sensing signal AI-2 (luxS, PQ, OU).
Consistent with this finding, earlier work demonstrated that V.
cholerae produces AI-2 (21, 22). However, the V. cholerae
target(s) controlled by this putative quorum-sensing circuit, if
any, remained unknown. Here we show that the V. harveyi-like
quorum-sensing regulators are involved in controlling V. chol-
erae virulence gene expression. Surprisingly, in contrast to other
bacterial species in which quorum sensing activates virulence
gene expression at high cell densities, in V. cholerae, quorum
sensing appears to repress ToxR-regulated virulence genes.
Materials and Methods
Bacterial Strains, Plasmids, and Culture Conditions. V. cholerae El
Tor strain C6706 (23) was used as the parental strain in this
study. The method used for construction of the hapR and
luxO deletion mutants was that of Skorupski and Taylor (24).
The phapR plasmid was constructed by cloning the hapR ORF
into pBBR1MCS4 (25) downstream of the constitutive plac
promoter. An isopropyl -D-thiogalactoside (IPTG)-inducible
hapR-expressing plasmid (pJZ146) was constructed by subclon-
ing the hapR gene into pMal-c2x (New England Biolabs).
pMal-c2x contains the ptac promoter and the lacIQ gene. Chro-
mosomal tcpP-lacZ and hapR-lacZ transcriptional reporter fu-
sions were constructed by PCR amplifying the 5 DNA of tcpP
and hapR, respectively, and cloning these fragments into
pVIK112 (26). The resulting plasmids were then integrated into
the chromosome at the tcpP and hapR loci, respectively, by
homologous recombination. When CT and TCP production was
required, V. cholerae strains were grown in AKI medium as
described (27). In all other experiments, V. cholerae strains were
propagated in LB at 37°C.
Abbreviations: CT, cholera enterotoxin; TCP, toxin-coregulated pilus; IPTG, isopropyl -D-
thiogalactoside; HA, hemagglutinin.
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Microarray Experiments. The production of spotted microarrays
containing full-length ORFs derived from V. cholerae strain
N16961 has been described (28). RNA was isolated from cells
grown in AKI medium by using TRIzol reagent (GIBCOBRL),
extracted with hot phenol (pH 5.2, 65°C), and purified by using
a RNeasy kit (Qiagen, Chatsworth, CA). Fluorescently labeled
cDNA was prepared by direct incorporation of fluorescent
nucleotide analogues (Cy3-dCTP and Cy5-dCTP) during a first-
strand randomly primed reverse transcription reaction. The
differentially labeled cDNAs were combined and subsequently
applied to the array surface under conditions that favor hybrid-
ization (28). Microarray slides were scanned by using a ScanAr-
ray 5000 apparatus (GSI Lumonics, Watertown, MA). For every
ORF-specific spot, the resulting fluorescence intensity of each of
the labels was measured and compared by using the GENEPIX PRO
3.0 software system (Axon Instruments, Foster City, CA).
Detection of CT, TCP, and Hemagglutinin (HA) Protease. GM1 gan-
glioside enzyme-linked immunosorbent CT assays (29) were
performed after incubation of V. cholerae strains for 5 h at 37°C,
with aeration in AKI medium. Cell extracts prepared from
cultures used for CT assays were subjected to SDSPAGE,
transferred to nitrocellulose membranes, probed with anti-TcpA
antibody (30), and visualized by using the enhanced chemilumi-
nescence detection system (Amersham Pharmacia). HA pro-
tease azocasein assays were performed as described (31). Zy-
mograms were performed by incorporating 0.2% (final) gelatin
into 7% SDSPAGE gels. Sample buffer was added to culture
supernatants that subsequently were applied to the gels without
boiling. After electrophoresis, gels were rinsed for 30 min in
2.5% and then 1% Triton X-100, followed by three rinses in
protease buffer (0.1 M Tris, pH 80.5 mM CaCl2). In-gel
protease activity was allowed to proceed overnight in protease
buffer at 37°C, after which gels were stained with Coomassie
blue.
Biofilm Assays. Overnight cultures of V. cholerae were inoculated
at a 1:100 dilution into LB broth and incubated in borosilicate
tubes for 18 h at 22°C. Subsequently, the tubes were rinsed with
distilled water then filled with crystal violet stain. After 5 min,
the tubes were rinsed. The biofilm-associated crystal violet was
resuspended with DMSO, and the OD570 of the resulting sus-
pension was measured.
Infant Mouse Colonization Assay. The infant mouse colonization
assay has been described (32). Briefly, V. cholerae mutant strains
(Lac) were mixed with the wild-type strain (Lac), and ap-
proximately 105 cells were inoculated into 5- to 6-day-old CD-1
suckling mice. After a 20 h period of colonization, intestinal
homogenates were collected, and the ratio of mutantwild-type
bacteria was determined by plating on LB agar containing
5-bromo-4-chloro-3-indolyl -D-galactoside.
Results
LuxO Is Required for V. cholerae to Colonize Mice. The V. harveyi
luxCDABE operon was used as a heterologous target in V.
cholerae to test for quorum-sensing regulation. This study re-
vealed that wild-type V. cholerae expresses luminescence in a cell
density-dependent manner, a luxO mutant displays maximal
constitutive luminescence, and a hapR mutant produces no light
(M.B.M. and B.L.B., unpublished work). These lux expression
patterns correspond exactly to those of the analogous V. harveyi
strains, confirming that the V. harveyi-like quorum-sensing cir-
cuit is operational in V. cholerae, and also that the V. cholerae
LuxO and HapR proteins are functional homologues of the V.
harveyi LuxO and LuxR proteins, at least with respect to
regulation of luciferase. However, V. cholerae does not possess
a luciferase operon, so it is not clear what the endogenous
quorum-sensing controlled targets are in this bacterium. The
only previously characterized role for HapR is in regulation of
expression of the HA protease (19).
In an effort to determine the targets of quorum sensing in V.
cholerae, we tested whether mutations in luxO andor hapR
affect V. cholerae pathogenesis. To do this we performed an in
vivo colonization assay using the infant mouse model. Six-day-
old suckling CD-1 mice were infected with 1:1 mixtures of
overnight-cultured wild-type and luxO mutants and wild-type
and hapR mutants. Mice were killed after 20 h, and the small
intestine was analyzed to determine the ratio of wild-type to
mutant bacteria. Wild-type bacteria could be distinguished from
the mutant strains by virtue of a lacZ deletion that does not affect
virulence. Table 1 shows our results. The hapR mutant colonizes
infant mice to the same extent as wild-type V. cholerae (com-
petitive index  1). In contrast, the luxO mutant is profoundly
defective in colonization, as not a single luxO mutant bacterium
was recovered from the small intestines of any of the 12 mice
used in the experiment. Therefore the competitive index for the
luxO mutant is 104.
LuxO Regulates Virulence Gene Expression. To investigate the mech-
anism by which LuxO regulates V. cholerae pathogenicity, we
performed whole-genome DNA microarray experiments and com-
pared the transcription profiles of the wild-type and luxO mutants.
In this experiment we used in vitro conditions (AKI medium) that
are known to induce the expression of virulence factors. Our results
are presented in Fig. 1 and Table 2. Fig. 1 shows that, relative to the
wild-type strain, many genes are activated and many are repressed
in the luxO mutant. However, higher expression of all of the genes
in the ToxR-virulence regulon occurs in the wild-type strain com-
Table 1. Infant mouse colonization assays
Strains Competitive index
hapR 1.2
luxO 6.7  104
luxOhapR 0.38
Assays were performed as described in Materials and Methods. The com-
petitive index represents the ratio of output mutant to wild type (recovered
from the intestine) divided by the ratio of input mutant to wild type (inocu-
lated into the mouse). The P value for each independent experiment is0.05
as determined by using the Student’s t test.
Fig. 1. Gene expression profiles for wild-type C6706 and the luxO V. cholerae
mutant. Genes with higher expression in the wild-type strain compared with
the luxO mutant are shown in red. Genes expressed at higher levels in the luxO
mutant compared with the wild-type strain are shown in green. Black dots
represent genes that displayed less than 3-fold variation between the two
strains. * indicate genes known to be essential for virulence.
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pared with the luxO mutant. The differences in expression level for
all of the LuxO-regulated genes are given in Table 2. Again, these
data clearly show that the entire ToxR regulon is repressed in the
luxO mutant. For example, genes in the TCP island are repressed
2.7- to 41.7-fold in the luxO mutant. Similarly, the ctxA and ctxB
genes, which are transcribed in an operon and encode the two
subunits of CT, are also strongly inhibited (40-fold) in the luxO
mutant.
To verify the microarray data, we examined the production of
two major virulence determinants, CT and TcpA, after growth
in AKI medium under exactly the same conditions we used in the
microarray experiment. Our results show that the luxO mutant
does not produce any detectable TcpA (Fig. 2 Upper) or CT (Fig.
2 Lower). These data are consistent with the microarray exper-
iment and explain why the luxO mutant fails to colonize mice.
LuxO Acts at the Level of tcpP Expression. Two parallel signal
transduction cascades coordinately regulate virulence in V.
cholerae (33). The ToxR–ToxS and the TcpP–TcpH signaling
circuits detect and respond to environmental stimuli, and both
circuits exert their regulatory control over virulence by influ-
encing the expression of toxT. ToxT, in turn, activates the
transcription of a variety of genes required for virulence (34). To
study the mechanism of repression of the virulence regulon in
the luxO mutant, we constitutively expressed ToxR, TcpP, and
ToxT (33) in the luxO mutant and tested whether overexpression
of any of these genes could bypass the luxO defect and restore
the mutant to CT production. Fig. 3A shows that constitutive
expression of toxR does not affect CT production in the luxO
mutant. However, CT is produced when either tcpP or toxT is
constitutively expressed in the luxO mutant. This result indicates
that the LuxO effect on the virulence regulon is mediated
through down-regulation of TcpP. Consistent with this hypoth-
esis, the microarray data in Table 2 show that 16.6-fold lower
Table 2. Differential gene expression in the luxO mutant in
AKI medium
ORF ID
Fold
activation
Pathogenesis
ToxR-activated gene A protein, TagA VC0820 3.6
TagD protein VC0824 13.4
Toxin coregulated pilus biosynthesis protein, TcpI VC0825 7.5
Toxin coregulated pilus biosynthesis protein, TcpP VC0826 16.6
Toxin coregulated pilus biosynthesis protein, TcpH VC0827 10.2
Toxin coregulated pilin, TcpA VC0828 41.7
Toxin coregulated pilus biosynthesis protein, TcpB VC0829 29.3
Toxin coregulated pilus biosynthesis protein, TcpQ VC0830 22.1
Toxin coregulated pilus biosynthesis protein, TcpC VC0831 35.9
Toxin coregulated pilus biosynthesis protein, TcpR VC0832 18.8
Toxin coregulated pilus biosynthesis protein, TcpD VC0833 37.8
Toxin coregulated pilus biosynthesis protein, TcpS VC0834 53.9
Toxin coregulated pilus biosynthesis protein, TcpT VC0835 29.7
Toxin coregulated pilus biosynthesis protein, TcpE VC0836 26.9
Toxin coregulated pilus biosynthesis protein, TcpF VC0837 45.0
TCP pilus virulence regulatory protein, ToxT VC0838 2.7
Leader peptidase, TcpJ VC0839 18.0
Accessory colonization factor, AcfB VC0840 19.7
Accessory colonization factor, AcfC VC0841 16.3
TagE protein VC0843 10.5
Accessory colonization factor, AcfA VC0844 28.4
Cholera enterotoxin, B subunit, CtxB VC1456 40.4
Cholera enterotoxin, A subunit, CtxA VC1457 39.5
Haemolysin, HlyA VCA0219 6.9
Membrane proteins or secretion
Transporter, NadC family VCA0025 6.3
Outer membrane protein, OmpV VC1318 4.5
Iron(III) ABC transporter VCA0687 3.6
Amino acid ABC transporter VC1362 4.9
Porin, OmpT VC1854 5.5
Metabolism
Aldehyde dehydrogenase, AldA-1 VC0819 12.7
Glycerol kinase, GplK VCA0744 5.3
Hydrolase VCA0877 6.9
Acetyl-CoA acetyltransferase VCA0690 8.1
Polyhydroxyalkanoic acid synthase, PhaC VCA0688 9.1
Acetoacetyl-CoA reductase VCA0691 9.9
Chemotaxis and motility
Methyl-accepting chemotaxis protein VC1248 6.3
Purine-binding chemotaxis protein, CheW VC1402 5.5
Methyl-accepting chemotaxis protein VC1403 4.9
Methyl-accepting chemotaxis protein VCA0031 3.4
Chemotactic transducer-related protein VCA0895 4.0
Methyl-accepting chemotaxis protein VCA0979 4.2
Methyl-accepting chemotaxis protein VCA1092 4.8
Chemotaxis protein, CheA VCA1095 3.8
Chemotaxis protein, CheY VCA1096 3.7
Regulation
Sensory box sensor histidine kinase VCA0211 3.6
Hemagglutininprotease regulatory protein, HapR VC0583 6.9
Unknown functions
Enterobactin synthetase VC1579 9.9
Hcp protein VC1415 4.8
Hcp protein VCA0017 7.1
Positive values represent activation in luxO mutants, negative values rep-
resent repression. Expression of 20 other conserved hypothetical genes and
hypothetical genes is changed greater than 3-fold in luxO mutants (data not
shown).
Fig. 2. CT and TcpA production in wild-type C6706 and mutant V. cholerae
strains. Samples were prepared after 5 h incubation in AKI medium with
aeration at 37°C. (Upper) Cell pellets from the specified strains were subjected
to Western blot and probed with anti-TcpA antibody. (Lower) The correspond-
ing cell-free culture fluids were assayed in GM1 ganglioside enzyme-linked
immunosorbent CT assays.
Fig. 3. LuxO represses tcpP expression. (A) toxR, tcpP, and toxT were cloned
into the expression vector pBAD24 (33), and the plasmids were introduced
into the V. cholerae luxO mutant. Subsequently, the strains were grown under
AKI-inducing conditions in the presence of 0.01% arabinose. CT production
was quantitated after 5 h incubation at 37°C with aeration. The data are
presented as the percentage of CT production of the wild-type bearing the
same plasmids. (B) tcpP-lacZ expression was assayed in the wild type, the luxO
mutant, and the wild-type strain constitutively expressing a cloned hapR gene
(denoted phapR). -galactosidase activity assays (39) were conducted after
growth with aeration for 5 h at 37°C in AKI medium.
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expression of tcpP occurs in the luxO mutant than in the
wild-type strain.
In an independent test to verify that LuxO activates tcpP
expression, we introduced tcpP-lacZ transcriptional reporter
fusions onto the chromosomes of the wild-type and luxO null
mutant. The -galactosidase activity of the tcpP-lacZ fusion was
measured in each strain, and we found that 40-fold less expres-
sion of the reporter occurs in the luxO mutant than in the wild
type (Fig. 3B). This result shows that transcription of tcpP
requires the presence of a functional LuxO protein.
LuxO Acts Through HapR to Control tcpP Expression. The microarray
experiment reveals that one of the genes regulated by LuxO is the
V. harveyi luxR homologue hapR. Specifically, hapR expression
increases 6.9-fold in the luxO mutant, suggesting that LuxO is a
repressor of hapR expression (Table 2). We therefore wondered
whether LuxO might affect tcpP expression indirectly, by acting
through HapR. We hypothesized that LuxO negatively regulates
hapR expression, and HapR in turn represses tcpP expression. To
test this idea, a plasmid containing a constitutively expressed
hapR gene was introduced into wild-type V. cholerae. The
resulting recombinant strain fails to produce TCP and CT under
our standard inducing conditions (Fig. 2), indicating that HapR
is involved in repression of the ToxR regulon. Consistent with
this result, Fig. 3B shows that in a wild-type strain, constitutive
expression of hapR results in nearly complete repression of the
tcpP-lacZ reporter fusion. Microarray analysis also demonstrates
that constitutive expression of hapR results in a transcriptional
profile of V. cholerae virulence genes very similar to that of the
luxO mutant (data not shown). Taken together, these data
suggest that HapR acts downstream of LuxO to repress tcpP
expression, and this action ultimately results in repression of the
ToxR virulence regulon.
To confirm our predictions regarding the roles of LuxO and
HapR in virulence gene regulation, we performed an epistasis
test to show that HapR indeed acts downstream of LuxO. We
constructed a luxO, hapR double null mutant and tested CT and
TCP production as well as the ability of the double mutant to
colonize mice. The double mutant produces wild-type levels of
both CT and TCP (Fig. 2), and this mutant has, at most, only a
minor colonization defect (Table 1). These data show that hapR
is epistatic to luxO and that LuxO is therefore not required to
directly activate the tcpP promoter. Rather, LuxO controls tcpP
expression indirectly by repressing expression of hapR, which in
turn represses tcpP expression. We do not know whether HapR
acts directly or indirectly to repress tcpP transcription. In general,
HapR and its homologues in other Vibrio species (LuxR, SmcR,
and OpaR) act as transcriptional activators (17, 18, 36, 37). As
mentioned previously, HapR activates the expression of luxC-
DABE in V. cholerae. Many activators are also repressors,
however, and HapR could possess both activities. Alternatively,
HapR could activate a downstream repressor of tcpP expression.
LuxO Regulation of hapR Expression. Our data suggest that HapR
plays an important role in the quorum-sensing regulation of V.
cholerae virulence factors. To further investigate how HapR
functions in regulation of the virulence process, we monitored
the expression of a hapR-lacZ transcriptional fusion in the
wild-type and the luxO mutant V. cholerae strains as a function
of cell density. Fig. 4A shows that hapR is expressed at low cell
densities in the luxO null mutant, but not at low cell densities in
wild-type V. cholerae. However, by the time the strains reach late
log-phase, expression of hapR is identical in the wild-type and the
luxO mutant. We interpret this result to imply that initial but not
late expression of hapR in the luxO mutant is critical for the
inhibition of virulence factor production.
A model in which early but not late expression of hapR
represses virulence gene expression predicts that induction of
hapR at late times should not influence the production of
virulence factors. To test this idea, we introduced a plasmid
containing an IPTG-inducible hapR gene construction into
wild-type V. cholerae C6706. IPTG was added at different time
points during growth, and CT production was assayed after 10 h
of incubation. Fig. 4B shows the level of CT production in
HapR-expressing cells compared with that produced by a strain
containing a vector control. Fig. 4B shows that the HapR
inhibitory effect on CT production is observed only when hapR
is induced at early time points, even though SDSPAGE analysis
showed that the total HapR protein made by 10 h was similar
regardless of whether IPTG was added at 0 h or 8 h (data not
shown). These data indicate that, at least in vitro, HapR acts at
an early stage of growth to repress virulence factor production.
It remains unclear how HapR regulates virulence gene expres-
sion in vivo.
LuxO and HapR Proteins Control Multiple Processes in V. cholerae. We
investigated whether LuxO and HapR might control multiple
cellular processes in addition to pathogenesis. As mentioned,
HapR is required for production of the HA protease (19). The
HA protease is encoded by the hapA gene, and it is a major
extracellular protease that may serve as a ‘‘detachase’’ during
colonization (38). Zymogram analysis (Fig. 5A) of 17 h cell-free
spent culture fluids from the V. cholerae hapR and hapA mutants
shows that, as expected, these mutants produce no HA protease.
Quantitative analysis of the protease activities of the hapR
mutant shows that it is very similar to that of the hapA mutant
(Fig. 5). In contrast, identical preparations made from the luxO
mutant resulted in a zymogram and protease activity profile
similar to that of the wild type (Fig. 5). Interestingly, our analyses
demonstrate that higher levels of protease are present in cell-free
spent culture fluids prepared from a luxO-hapA double mutant
than from the hapA single mutant (Fig. 5B). This result indicates
Fig. 4. LuxO regulation of hapR expression and HapR regulation of CT
production. (A) Wild-type and luxO mutants carrying a chromosomal hapR-
lacZ reporter fusion were grown in AKI medium at 37°C. Samples were
withdrawn at the specified ODs, and -galactosidase activity was assayed. F,
wild type (wt);Œ, luxO mutant. (B) Wild-type V. cholerae containing the vector
pMal-c2x or carrying pJZ146 (pMal-c2X containing hapR under IPTG control)
were grown as described in AKI medium, and IPTG (50M final concentration)
was added at the indicated time points. All of the samples were assayed for CT
production after a total of 10 h at 37°C. The data are presented as the
percentage of CT production in the V. cholerae strain carrying pJZ146 com-
pared with the strain carrying only the vector pMal-c2x.
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that LuxO negatively regulates secreted proteases other than the
HA protease. Additionally, the time course of protease produc-
tion (Fig. 5B) shows that protease activity is produced earlier in
the luxO mutant than in the wild type. We suggest that this LuxO
regulation is exerted through HapR, which is consistent with our
finding that LuxO represses hapR expression only at low cell
density.
The microarray data presented in Table 2 show that the
expression of several genes involved in chemotaxis and motility
are altered in the luxO mutant. We examined the motility of the
luxO mutant on a swarm plate and found that this mutant is less
motile than the wild-type and hapR mutant strains (Fig. 6A). We
also tested whether LuxO and HapR are involved in biofilm
formation. Photographs and crystal violet quantifications of
biofilms produced by the wild-type, luxO, and hapR mutants are
shown in Fig. 6B. Compared with wild-type V. cholerae, the luxO
mutant is deficient in its ability to form a biofilm, whereas the
hapR mutant is increased in its ability to form a biofilm.
Discussion
Bacteria coordinately control gene expression to adapt to and
survive in fluctuating environmental conditions. For example,
the human pathogen V. cholerae possesses a virulence regulon of
more than 20 genes involved in colonization, toxin production,
and bacterial survival within the host (33, 34). The virulence
regulon is under the control of a cascade of transcriptional
regulators that includes ToxR, TcpP, and ToxT. These regulators
are hypothesized to respond to external cues such as tempera-
ture, pH, and osmolarity. In this study, we demonstrate a central
role for the quorum-sensing proteins LuxO and HapR in the
regulation of virulence gene expression in V. cholerae. The data
presented here suggest that LuxO negatively regulates the ex-
pression of HapR, which in turn represses the expression of the
essential virulence gene regulator, TcpP.
It remains unclear how quorum signals and other environ-
mental cues are integrated to regulate virulence in vivo. One
speculative model (Fig. 7) proposes that on initial (low bacterial
cell density) colonization of a host by V. cholerae LuxO represses
hapR and allows the expression of tcpP. This, in turn, results in
the expression of the virulence factors in the ToxR regulon.
These virulence factors enable V. cholerae to colonize the small
intestine, multiply, and produce cholera toxin. When a high cell
density is reached, autoinducer accumulates, and LuxO no
longer represses hapR expression. Subsequent production of
HapR presumably represses tcpP and ToxR regulon expression.
In contrast, at high cell density, HapR activates the expression
of hapA, which encodes the HA protease. Protease expression
might promote detachment of V. cholerae cells, and thus facil-
itate establishment of new infection foci elsewhere within the
gastrointestinal tract, or alternatively, promote the exit of V.
cholerae from the host. Repression of the TCP, a type IV pilus
proposed to mediate bacterial-bacterial adhesion, also might
promote detachment of V. cholerae from the epithelium. It
should be noted that, although we have demonstrated an un-
equivocal role for LuxO and HapR in virulence gene expression,
our studies have not yet shown that virulence genes are respon-
sive to autoinducers that accumulate at high cell density.
Interestingly, several toxigenic V. cholerae strains (e.g., El Tor
strain N16961 and classical strain O395) possess a natural
frame-shift mutation in the hapR gene (data not shown). These
strains express low levels of HA protease, and a mutation in luxO
does not result in a CT production defect (data not shown and
ref. 39). This phenotype is similar to what we show here for the
luxO-hapR double mutant. It is important to note that negative
regulation of the hapR homologue luxR by LuxO in V. harveyi has
not been observed. Therefore, this variation in the regulatory
circuit could be unique to V. cholerae. We speculate that
elimination of HapR, either by mutation or LuxO repression,
may be an evolutionary step that improves V. cholerae adaptation
Fig. 5. HA protease production in V. cholerae wild-type and mutant strains.
(A) Zymogram analyses of cell-free culture fluids prepared from the desig-
nated V. cholerae parent and isogenic mutant strains after 17 h incubation at
37°C are shown. In lanes prepared from samples containing high HA protease
activity [wild type (wt) and luxO], the HA protease results in complete clearing
of the gelatin because the HA protease is active during the electrophoresis
run. (B) A time course of HA protease production is shown for the same strains
analyzed in A. Overnight cultures were diluted 1:100 in LB and incubated at
37°C. Samples were taken at 2-h intervals for determination of azocasein
activity. One azocasein unit is defined as the amount of enzyme producing an
increase of 0.01 OD units per h.
Fig. 6. LuxO and HapR control multiple processes in V. cholerae. (A) Differ-
ent V. cholerae strains were inoculated into motility agar (LB containing 0.3%
agar) and incubated at 37°C for 4 h, after which the photograph was taken. (B)
A comparison of biofilms produced by wild-type V. cholerae and the luxO and
hapR mutants. (Upper) The photograph shows the crystal violet staining in the
borosilicate tubes containing the different strains. The normalized data are
presented for these assays (Lower). The OD570 values are a measure of crystal-
violet staining, which is proportional to the level of biofilm formation. The
designation wt refers to the wild-type strain.
Fig. 7. A model for quorum-sensing regulation of V. cholerae virulence.
Solid arrows denote positive effects while solid T bars denote negative effects.
At low cell density, LuxO is active and represses the expression of hapR. HapR
is a negative regulator of tcpP transcription, so under this condition, the TcpP
signaling protein is present and it, together with TcpH and ToxRS, activates the
expression of virulence factors TCP and CT. In contrast, at high cell density,
LuxO is inactive as a result of autoinducer signal accumulation. Inactivation of
LuxO results in hapR expression at high cell density. HapR represses TcpP and
the ToxR regulon and activates Hap protease expression.
Zhu et al. PNAS  March 5, 2002  vol. 99  no. 5  3133
M
IC
RO
BI
O
LO
G
Y
to the human host. Presumably, loss or down-regulation of HapR
is advantageous for survival in andor colonization of the host
by prolonging TCP and CT expression even at high cell density.
It is also likely that loss of HapR results in low HA protease
production, which in turn could restrict detachment of bacteria
from the intestinal epithelium. Thus, vibrios lacking HapR might
remain attached to the epithelium for longer times. This could
prolong colonization and the duration of shedding of vibrios in
the stools of cholera sufferers. Also, as we have demonstrated,
hapR mutants form thicker biofilms, and this may aid in their
persistence within the host. Further studies should address how
quorum-sensing autoinducers and other signals are coordinated
to regulate the broad array of virulence-associated phenotypes
of V. cholerae.
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